Cite
Wong ET, Lok E, Gautam S, et al. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer. 2015;113(11):1642doi: 10.1038/bjc.2015.404.
Wong, E. T., Lok, E., Gautam, S., & Swanson, K. D. (2015). Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. British journal of cancer, 113(11), 1642. https://doi.org/10.1038/bjc.2015.404
Wong, E T, et al. "Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma." British journal of cancer vol. 113,11 (2015): 1642. doi: https://doi.org/10.1038/bjc.2015.404
Wong ET, Lok E, Gautam S, Swanson KD. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer. 2015 Dec 01;113(11):1642. doi: 10.1038/bjc.2015.404. PMID: 26625224; PMCID: PMC4705903.
Copy
Download .nbib